Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.

A Advani, B Coiffier, MS Czuczman, M Dreyling, J Foran, E Gine, C Gisselbrecht, N Ketterer, S Nasta, A Rohatiner, IG Schmidt-Wolf, M Schuler, J Sierra, MR Smith, G Verhoef, JN Winter, J Boni, E Vandendries, M Shapiro, L Fayad

Research output: Contribution to journalArticleResearch

266 Citations (Scopus)
Original languageEnglish
Pages (from-to)2085-2093
JournalJ Clin Oncol
Issue number12
Publication statusPublished - 1 Jan 2010

Cite this